Cargando…

Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’

Detalles Bibliográficos
Autores principales: von Rotz, Robin, Schindowski, Eva M., Jungwirth, Johannes, Schuldt, Anna, Rieser, Nathalie M., Zahoranszky, Katharina, Seifritz, Erich, Nowak, Albina, Nowak, Peter, Jäncke, Lutz, Preller, Katrin H., Vollenweider, Franz X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898017/
https://www.ncbi.nlm.nih.gov/pubmed/36747965
http://dx.doi.org/10.1016/j.eclinm.2023.101841
_version_ 1784882365712039936
author von Rotz, Robin
Schindowski, Eva M.
Jungwirth, Johannes
Schuldt, Anna
Rieser, Nathalie M.
Zahoranszky, Katharina
Seifritz, Erich
Nowak, Albina
Nowak, Peter
Jäncke, Lutz
Preller, Katrin H.
Vollenweider, Franz X.
author_facet von Rotz, Robin
Schindowski, Eva M.
Jungwirth, Johannes
Schuldt, Anna
Rieser, Nathalie M.
Zahoranszky, Katharina
Seifritz, Erich
Nowak, Albina
Nowak, Peter
Jäncke, Lutz
Preller, Katrin H.
Vollenweider, Franz X.
author_sort von Rotz, Robin
collection PubMed
description
format Online
Article
Text
id pubmed-9898017
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98980172023-02-05 Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’ von Rotz, Robin Schindowski, Eva M. Jungwirth, Johannes Schuldt, Anna Rieser, Nathalie M. Zahoranszky, Katharina Seifritz, Erich Nowak, Albina Nowak, Peter Jäncke, Lutz Preller, Katrin H. Vollenweider, Franz X. eClinicalMedicine Corrigendum Elsevier 2023-01-30 /pmc/articles/PMC9898017/ /pubmed/36747965 http://dx.doi.org/10.1016/j.eclinm.2023.101841 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Corrigendum
von Rotz, Robin
Schindowski, Eva M.
Jungwirth, Johannes
Schuldt, Anna
Rieser, Nathalie M.
Zahoranszky, Katharina
Seifritz, Erich
Nowak, Albina
Nowak, Peter
Jäncke, Lutz
Preller, Katrin H.
Vollenweider, Franz X.
Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
title Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
title_full Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
title_fullStr Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
title_full_unstemmed Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
title_short Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
title_sort corrigendum to ‘single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898017/
https://www.ncbi.nlm.nih.gov/pubmed/36747965
http://dx.doi.org/10.1016/j.eclinm.2023.101841
work_keys_str_mv AT vonrotzrobin corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT schindowskievam corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT jungwirthjohannes corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT schuldtanna corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT riesernathaliem corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT zahoranszkykatharina corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT seifritzerich corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT nowakalbina corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT nowakpeter corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT janckelutz corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT prellerkatrinh corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial
AT vollenweiderfranzx corrigendumtosingledosepsilocybinassistedtherapyinmajordepressivedisorderaplacebocontrolleddoubleblindrandomisedclinicaltrial